IL1B and cardiovascular disorder: Elevated IL-1β activity contributes to the pathogenesis of conditions such as insulin resistance, adverse cardiac remodeling, and heart failure and it thus emerged as a therapeutic target, especially for inflammatory, metabolic, and cardiovascular diseases [96,97].